Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
15-Aug-25 | Buy | Roch Doliveux | 449.75p | 67,000 | £301,332.50 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
15-Aug-25 | Buy | Roch Doliveux | 449.75p | 67,000 | £301,332.50 |
Notifier | Holding | Value* |
---|---|---|
Roch Doliveux | 376,808 | £1,863,316 |
Heather Preston | 29,687 | £146,802 |
Frank Mathias | 20,000 | £98,900 |
Namrata P Patel | 9,170 | £45,346 |
Dame Kay Davies | 1,000 | £4,945 |
Notifier** | Holding | Value* |
---|---|---|
Briarwood Chase Management LLC | 13,851,927 | £68,497,779 |
Novo Nordisk Foundation | 12,048,802 | £59,581,326 |
Institut Merieux SA | 11,510,481 | £56,919,328 |
Briarwood Chase Management LLC | 11,171,966 | £55,245,372 |
VULPES LIFE SCIENCES FUND | 8,447,390 | £41,772,344 |
Liontrust Asset Management | 6,078,799 | £30,059,661 |
M&G Plc | 5,872,847 | £29,041,228 |
Legal & General Group Plc | 5,760,126 | £28,483,823 |
HSBC Global Custody Nominee (UK) Ltd | 4,700,000 | £23,241,500 |
Ameriprise Financial, Inc. | 4,108,146 | £20,314,782 |
Columbia Threadneedle Investments (London) | 3,834,977 | £18,963,961 |
Canaccord Genuity Group Inc | 3,699,438 | £18,293,721 |
Hargreaves Lansdown Asset Management | 3,475,237 | £17,185,047 |
SERUM LIFE SCIENCES LTD | 3,382,950 | £16,728,688 |
Nine Ten Capital | 3,117,228 | £15,414,692 |
Lansdowne Partners (London) | 3,085,765 | £15,259,108 |
Mr. S Shah | 2,898,750 | £14,334,319 |
Artisan Partners | 2,620,800 | £12,959,856 |
Cubana Investments Limited | 2,506,000 | £12,392,170 |
Interactive Investor Sharedealing | 2,372,412 | £11,731,577 |
TDWaterhouse | 852,076 | £4,213,516 |
Self Trade Stockbrokers | 657,039 | £3,249,058 |
Currency | UK Pounds |
Share Price | 494.50p |
Change Today | 55.00p |
% Change | 12.51 % |
52 Week High | 497.08 |
52 Week Low | 232.50 |
Volume | 566,990 |
Shares Issued | 106.20m |
Market Cap | £525.16m |
Beta | 0.02 |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
No dividends found |
Time | Volume / Share Price |
16:22 | 160 @ 493.50p |
16:35 | 84,858 @ 494.50p |
16:35 | 168 @ 494.50p |
16:35 | 1,894 @ 494.50p |
16:35 | 270 @ 494.50p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research